Skip to Main Content

Paper Details

Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study.
J Immunother Cancer
29
2020
Author NameAffiliation
Ming-Feng HouKaohsiung Medical University Chung Ho Memorial Hospital
Richard B SchwabMoores Cancer Center, University of California San Diego
  • 1 - 2

Datasets

Release 1.2